1 minute reading
Source/Disclosures Posted by: Source: Arepalli S, et al. The heterogeneous presentations of de-novo and recurrent uveitis after vaccination against COVID-19 – A multicenter report. Presented at: Women in Ophthalmology Summer Symposium; August 25-28, 2022. Monterey, California (hybrid meeting). Disclosures: Arepalli reports no relevant financial disclosures.
ADD SUBJECT TO EMAIL NOTIFICATIONS Receive an email when new articles are published Enter your email address to receive an email when new articles are published on . ” data-action=subscribe> Subscribe We were unable to process your request. Please try again later. If you continue to experience this problem, please contact [email protected] Back to Healio MONTEREY, Calif. — A study conducted at seven centers in the U.S. found that eye inflammation can occur in a minority of people after getting the COVID-19 vaccine. “The utility of vaccination against COVID-19 is indisputable. However, rarely, inflammation has been at least temporally associated with vaccination against COVID-19,” wrote Sruthi Arepalli, MD, and coauthors in a poster presented at the Women in Ophthalmology Summer Symposium. A retrospective chart review was performed on a cohort of 321 subjects. Inflammation after vaccination against COVID-19 occurred in 37 people. 22 (6.8%) had no history of ocular inflammation and 15 (4.6%) had a history of inflammation that had been quiescent for at least 3 months. The vaccines used were Pfizer and Moderna in the majority of cases. Flares included anterior, intermediate, posterior, and panangiitis, as well as scleritis, optic nerve edema, retinal vasculitis, cystoid macular edema, optic neuritis, and peripheral ulcerative keratitis. Five subjects in both the de novo and recurrent inflammation groups were HLA-B27 positive. Outbreaks occurred between 1 and 39 days after vaccination. Relief was achieved in most eyes, mainly with topical and oral corticosteroids.
ADD SUBJECT TO EMAIL NOTIFICATIONS Receive an email when new articles are published Enter your email address to receive an email when new articles are published on . ” data-action=subscribe> Subscribe We were unable to process your request. Please try again later. If you continue to experience this problem, please contact [email protected] Back to Healio
